Ebola outbreak worsens but a cure may be coming
Ebola — which first appeared in 1976 in the Congo and Sudan — is a brutal virus, with some strains killing up to 90 percent of people infected. People infected with Ebola, which is transmitted through bodily fluids such as blood, vomit, and diarrhea, can remain symptomless for between 2 and 21 days before being stricken with flu-like symptoms, diarrhea, and vomiting which can lead to the hemorrhaging of the eyes, mouth, and internal organs.
The current outbreak in West Africa is the biggest yet, killing 672 people since February, including at least two American citizens. The disease could potentially start spreading even faster after a Liberian man infected with the virus was allowed to board a plane that made a stopover in Ghana, changed planes in Togo, and died in Lagos, the world's fourth most populous city.
Some even worry that the disease could spread to the U.S. after the wife and children of a Texan doctor who came down with the virus were allowed to fly back to America. CDC director Tom Frieden says the CDC is ready for the possibility: "We do not anticipate this will spread in the U.S. if an infected person is hospitalized here, but we are taking action now by alerting healthcare workers in the U.S. and reminding them how to isolate and test suspected patients while following strict infection control procedures."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The only happy news is that the disease is showing signs of becoming more treatable. Deborah-Fay Ndhlovu of Nature points to a 2012 study that showed that "monkeys infected with Ebola have been cured by a cocktail of three antibodies first administered 24 hours or more after exposure. The result raises hopes that a future treatment could improve the chances of humans surviving the disease caused by the deadly virus."
But sadly, even if this research leads to an effective human treatment, a cure in monkeys is no use to humans infected today.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
John Aziz is the economics and business correspondent at TheWeek.com. He is also an associate editor at Pieria.co.uk. Previously his work has appeared on Business Insider, Zero Hedge, and Noahpinion.
-
Melting polar ice is messing with global timekeeping
Speed Read Ice loss caused by climate change is slowing the Earth's rotation
By Peter Weber, The Week US Published
-
The Week contest: Stick guitar
Puzzles and Quizzes
By The Week US Published
-
'Sports executives ushered a fox into the henhouse'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published
-
Anger may be a powerful motivator for tough goals, new study suggests
Speed Read Keeping your cool might actually be less efficient than letting your anger drive you
By Theara Coleman, The Week US Published
-
A tropical skin disease is making the rounds in the US
Speed Read Leishmaniasis is endemic to the country and can cause ulcers and disfiguration
By Devika Rao, The Week US Published